EUVIMEDEUVIMED entdecken
Crossref

The mechanism of action of Botrychium (Thunb.) Sw. for prevention of idiopathic pulmonary fibrosis based on 1H-NMR-based metabolomics

Yutao Lou iD, Xiaozhou Zou, Zongfu Pan, Zhongjie Huang, Shuilian Zheng, Xiaowei Zheng, Xiuli Yang, Meihua Bao, Yuan Zhang, Jinping Gu, Yiwen Zhang

Journal of Pharmacy and Pharmacology · 01.08.2024 · 76 (8) · 1018-1027

DOI: 10.1093/jpp/rgae058 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, online erschienen am 01.08.2024. Verfasst von Yutao Lou und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Center for Clinical Pharmacy, Cancer Center, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou M…. Hauptthemen laut MEDLINE: Idiopathic Pulmonary Fibrosis, Metabolomics, Bleomycin, Lung. Die Arbeit wurde bisher 68-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Zhejiang Provincial Department of Science and Technology, Chinese Medicine Research Program of Zhejiang Province, Zhejiang Province Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

This study aimed to reveal the anti-fibrotic effects of Botrychium ternatum (Thunb.) Sw. (BT) against idiopathic pulmonary fibrosis (IPF) and to preliminarily analyze its potential mechanism on bleomycin-induced IPF rats.

Methods

The inhibition of fibrosis progression in vivo was assessed by histopathology combined with biochemical indicators. In addition, the metabolic regulatory mechanism was investigated using 1H-nuclear magnetic resonance-based metabolomics combined with multivariate statistical analysis. Key findings Firstly, biochemical analysis revealed that BT notably suppressed the expression of hydroxyproline and transforming growth factor-β1 in the pulmonary tissue. Secondly, Masson’s trichrome staining and hematoxylin and eosin showed that BT substantially improved the structure of the damaged lung and significantly inhibited the proliferation of collagen fibers and the deposition of extracellular matrix. Finally, serum metabolomic analysis suggested that BT may exert anti-fibrotic effects by synergistically regulating tyrosine metabolism; phenylalanine, tyrosine and tryptophan biosynthesis; and synthesis and degradation of ketone bodies.

Conclusions

Our study not only clarifies the potential anti-fibrotic mechanism of BT against IPF at the metabolic level but also provides a theoretical basis for developing BT as an effective anti-fibrotic agent.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Idiopathic Pulmonary FibrosisMetabolomicsBleomycinLungTransforming Growth Factor beta1Rats, Sprague-DawleyAnimalsMaleRatsHydroxyprolineDisease Models, AnimalProton Magnetic Resonance SpectroscopyAntifibrotic AgentsTyrosineKetone BodiesCollagenPhenylalanineExtracellular MatrixPlant ExtractsTryptophanDrugs, Chinese Herbal

Stichwörter der Autor:innen

Botrychium ternatum (Thunb.) Swidiopathic pulmonary fibrosismetabolomicsnuclear magnetic resonance

Substanzen

BleomycinTransforming Growth Factor beta1HydroxyprolineAntifibrotic AgentsTyrosineKetone BodiesCollagenPhenylalaninePlant ExtractsTryptophan

Autor:innen und Institutionen

  • Department of Pharmacy, Center for Clinical Pharmacy, Cancer Center, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang 310014, China.
  • College of Pharmacy, Zhejiang University of Technology, Hangzhou, Zhejiang 310014, China.
  • Academician Workstation, School of Stomatology, Changsha Medical University, Changsha, Hunan 410219, China.
  • Department of Pharmacy, Zhejiang Provincial People' s Hospital Bijie Hospital, Bijie, Guizhou 551799, China.
  • Key Laboratory of Endocrine Gland Diseases of Zhejiang Province, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang 310014, China.

ORCID-Profile: Yutao Lou

Förderung

  • Zhejiang Provincial Department of Science and Technology
  • Chinese Medicine Research Program of Zhejiang Province
  • Zhejiang Province Natural Science Foundation of China
  • Medical and Health Research Program of Zhejiang
  • National Natural Science Foundation
  • Zhejiang Provincial Program for the Cultivation of New Heath Talents

Zitieren

APA

Lou, Y., Zou, X., Pan, Z., Huang, Z., Zheng, S., Zheng, X., Yang, X., Bao, M., Zhang, Y., Gu, J., & Zhang, Y. (2024). The mechanism of action of Botrychium (Thunb.) Sw. for prevention of idiopathic pulmonary fibrosis based on 1H-NMR-based metabolomics. Journal of Pharmacy and Pharmacology, 76(8), 1018-1027. https://doi.org/10.1093/jpp/rgae058

Vancouver

Lou Y, Zou X, Pan Z, Huang Z, Zheng S, Zheng X, et al. The mechanism of action of Botrychium (Thunb.) Sw. for prevention of idiopathic pulmonary fibrosis based on 1H-NMR-based metabolomics. Journal of Pharmacy and Pharmacology. 2024;76(8):1018-1027. doi:10.1093/jpp/rgae058

BibTeX
@article{Lou2024,
  author = {Lou, Yutao and Zou, Xiaozhou and Pan, Zongfu and Huang, Zhongjie and Zheng, Shuilian and Zheng, Xiaowei and Yang, Xiuli and Bao, Meihua and Zhang, Yuan and Gu, Jinping and Zhang, Yiwen},
  title = {The mechanism of action of Botrychium (Thunb.) Sw. for prevention of idiopathic pulmonary fibrosis based on 1H-NMR-based metabolomics},
  journal = {Journal of Pharmacy and Pharmacology},
  year = {2024},
  volume = {76},
  number = {8},
  pages = {1018--1027},
  doi = {10.1093/jpp/rgae058}
}
Kostenlos starten →